A detailed history of Sompo Asset Management Co., Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Sompo Asset Management Co., Ltd. holds 5,350 shares of ABBV stock, worth $963,000. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,350
Previous 5,630 4.97%
Holding current value
$963,000
Previous $965,000 9.43%
% of portfolio
0.17%
Previous 0.16%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $45,875 - $55,812
-280 Reduced 4.97%
5,350 $1.06 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $26,314 - $30,729
-170 Reduced 2.93%
5,630 $965,000
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $1.28 Million - $1.45 Million
-7,990 Reduced 57.94%
5,800 $1.06 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $221,536 - $249,501
1,610 Added 13.22%
13,790 $2.14 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $37,405 - $43,302
-280 Reduced 2.25%
12,180 $1.82 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $267,670 - $333,098
2,020 Added 19.35%
12,460 $1.68 Million
Q1 2023

May 09, 2023

SELL
$144.61 - $166.54 $331,156 - $381,376
-2,290 Reduced 17.99%
10,440 $1.66 Million
Q4 2022

Feb 01, 2023

SELL
$138.31 - $165.87 $8,298 - $9,952
-60 Reduced 0.47%
12,730 $2.06 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $385,182 - $441,779
2,870 Added 28.93%
12,790 $1.72 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $1.2 Million - $1.53 Million
-8,730 Reduced 46.81%
9,920 $1.52 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $1.61 Million - $2 Million
-12,190 Reduced 39.53%
18,650 $3.02 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $487,732 - $617,122
4,540 Added 17.26%
30,840 $4.18 Million
Q3 2021

Nov 09, 2021

SELL
$106.4 - $120.78 $545,832 - $619,601
-5,130 Reduced 16.32%
26,300 $2.84 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $159,919 - $178,159
1,520 Added 5.08%
31,430 $3.54 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $562,650 - $619,410
-5,500 Reduced 15.53%
29,910 $3.24 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $23,342 - $31,514
290 Added 0.83%
35,410 $3.79 Million
Q3 2020

Nov 06, 2020

SELL
$85.91 - $100.83 $94,501 - $110,913
-1,100 Reduced 3.04%
35,120 $3.08 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $85,842 - $114,870
1,170 Added 3.34%
36,220 $3.56 Million
Q1 2020

May 11, 2020

SELL
$64.5 - $97.79 $434,730 - $659,104
-6,740 Reduced 16.13%
35,050 $2.67 Million
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $188,980 - $236,455
-2,620 Reduced 5.9%
41,790 $3.7 Million
Q3 2019

Nov 01, 2019

BUY
$62.98 - $75.72 $2.8 Million - $3.36 Million
44,410 New
44,410 $3.36 Million
Q3 2017

Nov 13, 2017

SELL
$69.85 - $89.22 $3.69 Million - $4.71 Million
-52,840 Closed
0 $0
Q2 2017

Jan 04, 2018

SELL
N/A
-15,910 Reduced 23.14%
52,840 $3.83 Million
Q1 2017

Jan 04, 2018

SELL
N/A
-2,500 Reduced 3.51%
68,750 $4.48 Million
Q4 2016

Jan 04, 2018

BUY
N/A
71,250
71,250 $4.46 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sompo Asset Management Co., Ltd. Portfolio

Follow Sompo Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sompo Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sompo Asset Management Co., Ltd. with notifications on news.